IRVING, Texas, Oct. 23, 2025 /PRNewswire/ — NUU, Inc., through its enterprise arm, NUU for Business, today announced the release of its healthcare white paper, “From BYOD Apps to Provisioned, Locked Android Controllers: What Works Where—and Why.” The paper reframes mobile deployment choices in healthcare as patient-safety and compliance imperatives, not IT preferences. The paper concludes that while BYOD companion apps remain vital for scale and engagement, alarm authority should reside with a provisioned, locked Android controller—preferably a hardened AOSP build—to meet 2025 expectations under Federal Food, Drug, and Cosmetic Act (FD&C Act) 524B, FDA secure-by-design guidance, and ISO/IEC software lifecycle standards.
Key Findings
“Patient safety is the invariant. BYOD is excellent for reach, but when an alarm must fire every time, you need a locked, AOSP-based controller you can test, audit, and update on your schedule,” said Danny Sit, CEO of NUU, Inc. “That is how healthcare teams achieve deterministic alerts, reduce re-validation risk, and satisfy modern FDA cybersecurity expectations—without exploding total cost of ownership. This approach has directly improved reliability across connected care systems, contributing to better adherence, fewer critical events, and ultimately enhancing outcomes for hundreds of thousands of patients worldwide.”
What the paper provides:
The white paper is available from NUU for Business. To access the paper or discuss implementation for CGM/AID, RPM, telehealth, or inpatient programs, Download the healthcare white paper here.
About NUU for Business
Headquartered in Dallas, TX, NUU for Business designs and delivers best-in-class, adaptable Android hardware and software solutions for enterprises worldwide. From secure, turnkey devices to fully customized mobility solutions, NUU for Business is dedicated to empowering organizations to enhance communication, efficiency, and productivity. For more information, visit nuuforbusiness.com. We are your partner in custom-built Android™ devices and software.
Media Contact
NUU for Business- Communications
Gary So
608.572.8953
403493@email4pr.com
SOURCE NUU for Business
Telehealth Provider Offers FDA-Approved and Compounded Weight Loss Medications in All 50 States, Subject to…
Telehealth Platform Facilitates Compounded Semaglutide and Tirzepatide Access Through Licensed Provider Evaluation as FDA Shortage…
Analysis examines best peptides for boosting growth hormone as ReadyRx lists prescription sermorelin in injectable…
Discover the best fat burner for men in 2025. Explore Wolfson Brand’s effective fat-burning supplements…
Industry Analysis Examines How Cost, Safety, and Access Considerations Shape Semaglutide Choices as MEDVi Lists…
Deploying “Proof of Human” Infrastructure throughout Japan, a Technology Envisioned by Sam Altman and Alex…